1. Vimentin disruption by lipoxidation and electrophiles: Role of the cysteine residue and filament dynamics
- Author
-
Dolores Pérez-Sala, Sofia Duarte, Andreia Mónico, María A. Pajares, European Commission, Ministerio de Economía y Competitividad (España), Instituto de Salud Carlos III, Mónico, Andreia [0000-0003-4855-8241], Pajares, María A. [0000-0002-4714-9051], Pérez-Sala, Dolores [0000-0003-0600-665X], Mónico, Andreia, Pajares, María A., and Pérez-Sala, Dolores
- Subjects
0301 basic medicine ,Cyclopentenone prostaglandins ,Clinical Biochemistry ,FCCP, carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone ,HNE, 4-hydroxynonenal ,Vimentin ,DBB, dibromobimane ,Biochemistry ,Protein filament ,chemistry.chemical_compound ,Structure-function relationships of protein lipoxidation and mechanisms of action ,0302 clinical medicine ,Intermediate Filament Proteins ,Intermediate Filament Protein ,Intermediate filaments ,Phosphorylation ,Intermediate filament ,Cytoskeleton ,lcsh:QH301-705.5 ,lcsh:R5-920 ,biology ,Chemistry ,HRP, horseradish peroxidase ,Oxidants ,Lipids ,3. Good health ,Cell biology ,15d-PGJ2, 15-deoxy-Δ12,14-prostaglandin J2 ,lcsh:Medicine (General) ,Hydrophobic and Hydrophilic Interactions ,Oxidation-Reduction ,Protein Binding ,Calyculin ,macromolecular substances ,Models, Biological ,Cell Line ,Dephosphorylation ,03 medical and health sciences ,Vimentin filament morphology and dynamics ,Vimentin oxidation ,Cysteine ,EM, electron microscopy ,ECL, enhanced chemiluminiscence ,15d-PGJ2-B, biotinylated 15-deoxy-Δ12,14-prostaglandin J2 ,Organic Chemistry ,GFAP, glial fibrillary acidic protein ,FRAP, fluorescence recovery after photobleaching ,Lipid Metabolism ,cyPG, cyclopentenone prostaglandin(s) ,Lipoxidation ,Oxidative Stress ,HNE ,030104 developmental biology ,lcsh:Biology (General) ,biology.protein ,030217 neurology & neurosurgery - Abstract
15 p.-8 fig., The intermediate filament protein vimentin constitutes a critical sensor for electrophilic and oxidative stress, which induce extensive reorganization of the vimentin cytoskeletal network. Here, we have investigated the mechanisms underlying these effects. In vitro, electrophilic lipids, including 15-deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2) and 4-hydroxynonenal (HNE), directly bind to vimentin, whereas the oxidant diamide induces disulfide bond formation. Mutation of the single vimentin cysteine residue (Cys328) blunts disulfide formation and reduces lipoxidation by 15d-PGJ2, but not HNE. Preincubation with these agents differentially hinders NaClinduced filament formation by wild-type vimentin, with effects ranging from delayed elongation and increased filament diameter to severe impairment of assembly or aggregation. Conversely, the morphology of vimentin Cys328Ser filaments is mildly or not affected. Interestingly, preformed vimentin filaments are more resistant to electrophile-induced disruption, although chemical modification is not diminished, showing that vimentin (lip) oxidation prior to assembly is more deleterious. In cells, electrophiles, particularly diamide, induce a fast and drastic disruption of existing filaments, which requires the presence of Cys328. As the cellular vimentin network is under continuous remodeling, we hypothesized that vimentin exchange on filaments would be necessary for diamide-induced disruption. We confirmed that strategies reducing vimentin dynamics, as monitored by FRAP, including cysteine crosslinking and ATP synthesis inhibition, prevent diamide effect. In turn, phosphorylation may promote vimentin disassembly. Indeed, treatment with the phosphatase inhibitor calyculin A to prevent dephosphorylation intensifies electrophile-induced wild-type vimentin filament disruption. However, whereas a phosphorylation-deficient vimentin mutant is only partially protected from disorganization, Cys328Ser vimentin is virtually resistant, even in the presence of calyculin A. Together, these results indicate that modification of Cys328 and vimentin exchange are critical for electrophile-induced network disruption., This work was supported by the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie Grant agreement no. 675132 “Masstrplan”, Grant SAF2015-68590-R from MINECO/FEDER, Spain and Instituto de Salud Carlos III/FEDER,RETIC Aradyal RD16/0006/0021. Feedback from COST Action CA15214 “EuroCellNet” is gratefully acknowledged.
- Published
- 2019
- Full Text
- View/download PDF